All Stories

SCIENCE & INNOVATION 06.14.2022

Decoding Disease

Celebrating its 25th anniversary, deCODE genetics, an Amgen subsidiary, is studying the impact of human diversity on disease, improving drug discovery and development.
Read more

All Stories <i class="fa fa-angle-down"></i><i class="fa fa-angle-up"></i>

SCIENCE & INNOVATION 06.14.2022
Decoding Disease
Banner_360 x 244
SCIENCE & INNOVATION 08.19.2021
Introducing DNA Unlocked, the First Podcast From Amgen R&D Exploring Human Genetics to Transform Drug Research
new-insights-tile-desktop
SCIENCE & INNOVATION 12.21.2020
Polygenic Scores Poised to Play Big Role in Disease Prediction and Prevention
omics-tile-desktop
SCIENCE & INNOVATION 10.19.2020
Applying the Power of Omics to R&D
SCIENCE & INNOVATION 06.25.2020
A “Street View” Look at Immune Cells Battling Cancer Provides New Immunotherapy Leads
lp-a
SCIENCE & INNOVATION 12.17.2019
Landmark deCODE Study Sheds New Light on Role of Lp(a) in Heart Disease
SCIENCE & INNOVATION 09.10.2019
Amgen Joins Single Most Ambitious Whole Genome Sequencing Project Ever Undertaken